Pear Bio Overview

  • Status
  • Private

  • Employees
  • 24

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $16M

  • Investors
  • 19

Pear Bio General Information

Description

Developer of proprietary biomedical technologies designed for the treatment of cancer through the measurement of drug resistance in patients. The company's technology uses a proprietary hydrogel that can grow tumors outside the human body and replicate drug resistance to eliminate the trial and error process involved in cancer treatment, enabling patients to receive the right and effective treatment.

Contact Information

Website
www.pearbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
  • Camburgh House
  • 27 New Dover Road, Kent
  • Cantenbury CT1 3DN
  • England, United Kingdom
+44 0000000000

Pear Bio Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pear Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 14-Apr-2023 $16M 000.00 Completed Generating Revenue
9. Seed Round 01-Jan-2022 00.000 00.000 000.00 Completed Generating Revenue
8. Accelerator/Incubator 19-Oct-2021 00000 Completed Generating Revenue
7. Angel (individual) 03-Mar-2020 00000 Completed Generating Revenue
6. Accelerator/Incubator 20-Aug-2019 000.00 00000 00000 Completed Generating Revenue
5. Accelerator/Incubator 15-Jan-2019 000.00 000.00 00000 Completed Generating Revenue
4. Accelerator/Incubator 31-Mar-2017 000.00 Completed Generating Revenue
3. Accelerator/Incubator 10-Jun-2015 000.00 000.00 Completed Generating Revenue
2. Grant 11-May-2015 $10K Completed Generating Revenue
1. Accelerator/Incubator 01-Feb-2015 Completed Generating Revenue
To view Pear Bio’s complete valuation and funding history, request access »

Pear Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-5 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed-4 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed-3 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed-2 1,775,956 $0.000010 8% $0.07 $0.07 1x $0.07 7.3%
Seed-1 7,307,114 $0.000010 8% $0.46 $0.46 1x $0.46 28.59%
To view Pear Bio’s complete cap table history, request access »

Pear Bio Patents

Pear Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230008421-A1 Method of forming solid cell cultures Pending 08-Jul-2021 0000000000
US-20230010963-A1 Treatment efficacy prediction systems and methods Pending 08-Jul-2021 0000000000 00
US-20200121713-A1 Shear-thinning hydrogel, kit and method of preparation Active 29-Jan-2016 000000000
US-20170312306-A1 Shear-thinning hydrogel, kit and method of preparation Active 29-Jan-2016 000000000
US-10413567-B2 Shear-thinning hydrogel, kit and method of preparation Active 29-Jan-2016 A61K31/74
To view Pear Bio’s complete patent history, request access »

Pear Bio Executive Team (6)

Name Title Board Seat Contact Info
Duleek Ranatunga Co-Founder & Chief Executive Officer
You’re viewing 1 of 6 executive team members. Get the full list »

Pear Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pear Bio Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Covalent Ventures (CV) Venture Capital Minority 000 0000 000000 0
Octopus Ventures Venture Capital Minority 000 0000 000000 0
Compound Venture Capital Minority 000 0000 000000 0
Crista Galli Ventures Venture Capital Minority 000 0000 000000 0
Fly Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »